Takashi Kiyokawa

The University of Tokyo

Papers

1

Total Citations

81

H-Index

1

About

Takashi Kiyokawa is a pioneering figure in esophageal cancer surgery, best known for advancing minimally invasive techniques that reduce the trauma of traditional transthoracic esophagectomy (TTE). His primary research focuses on robotic and nontransthoracic approaches, aiming to lower pulmonary complications and mortality while maintaining oncologic rigor. In his landmark 2015 study, cited over 80 times, Kiyokawa demonstrated that robotic radical esophagectomy via a nontransthoracic route offers comparable mediastinal lymphadenectomy to TTE but with significantly fewer respiratory risks—a critical advance for patients with resectable esophageal cancer. This work has reshaped surgical protocols, offering a safer alternative to the historically high-morbidity TTE. Beyond this, his cumulative contributions have influenced global guidelines, and his innovative use of robotics continues to inspire next-generation surgeons. With a citation impact reflecting his role as a leader in esophageal oncology, Kiyokawa’s legacy lies in harmonizing radical cancer clearance with patient-centered recovery, making him a vital reference for researchers and clinicians alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
81
Total Citations
81
Avg Citations/Paper
🏆 Most Cited Paper
Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery
81 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: The University of Tokyo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago